Covid-19 Impact on Global Cannabis-based Medicines Market Size, Status and Forecast 2020-2026
Marijuana (medical cannabis) is used to treat nausea, pain, anxiety, MS, insomnia, epilepsy, and other conditions. Tetrahydrocannabinol (THC) and cannabidiol (CBD) are the main chemicals used in medicine. In the medicines market, Epidiolex, the first cannabis-based medication approved by the US Food and Drug Administration.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Cannabis-based Medicines market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Cannabis-based Medicines industry.
Based on our recent survey, we have several different scenarios about the Cannabis-based Medicines YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Cannabis-based Medicines will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Cannabis-based Medicines market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Cannabis-based Medicines market in terms of revenue.
Players, stakeholders, and other participants in the global Cannabis-based Medicines market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Cannabis-based Medicines market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Cannabis-based Medicines market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Cannabis-based Medicines market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Cannabis-based Medicines market.
The following players are covered in this report:
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Cannabis-based Medicines market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Cannabis-based Medicines industry.
Based on our recent survey, we have several different scenarios about the Cannabis-based Medicines YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Cannabis-based Medicines will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Cannabis-based Medicines market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Cannabis-based Medicines market in terms of revenue.
Players, stakeholders, and other participants in the global Cannabis-based Medicines market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Cannabis-based Medicines market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Cannabis-based Medicines market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Cannabis-based Medicines market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Cannabis-based Medicines market.
The following players are covered in this report:
- GW Pharmaceuticals plc
- INSYS Therapeutics
- Aequus Pharmaceuticals
- Axim Biotechnologies
- Revive Therapeutics
- MGC Pharmaceuticals
- ECHO Pharmaceuticals
- ...
- CBD (Cannabidiol) Based
- THC (Tetrahydrocannabinol) Based
- Others
- Oral Solution
- Tablets
- Patches
- Others
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Cannabis-based Medicines Revenue
1.4 Market Analysis by Type
1.4.1 Global Cannabis-based Medicines Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 CBD (Cannabidiol) Based
1.4.3 THC (Tetrahydrocannabinol) Based
1.4.4 Others
1.5 Market by Application
1.5.1 Global Cannabis-based Medicines Market Share by Application: 2020 VS 2026
1.5.2 Oral Solution
1.5.3 Tablets
1.5.4 Patches
1.5.5 Others
1.6 Coronavirus Disease 2019 (Covid-19): Cannabis-based Medicines Industry Impact
1.6.1 How the Covid-19 is Affecting the Cannabis-based Medicines Industry
1.6.1.1 Cannabis-based Medicines Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Cannabis-based Medicines Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Cannabis-based Medicines Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Cannabis-based Medicines Market Perspective (2015-2026)
2.2 Cannabis-based Medicines Growth Trends by Regions
2.2.1 Cannabis-based Medicines Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Cannabis-based Medicines Historic Market Share by Regions (2015-2020)
2.2.3 Cannabis-based Medicines Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Cannabis-based Medicines Market Growth Strategy
2.3.6 Primary Interviews with Key Cannabis-based Medicines Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Cannabis-based Medicines Players by Market Size
3.1.1 Global Top Cannabis-based Medicines Players by Revenue (2015-2020)
3.1.2 Global Cannabis-based Medicines Revenue Market Share by Players (2015-2020)
3.1.3 Global Cannabis-based Medicines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Cannabis-based Medicines Market Concentration Ratio
3.2.1 Global Cannabis-based Medicines Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Cannabis-based Medicines Revenue in 2019
3.3 Cannabis-based Medicines Key Players Head office and Area Served
3.4 Key Players Cannabis-based Medicines Product Solution and Service
3.5 Date of Enter into Cannabis-based Medicines Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Cannabis-based Medicines Historic Market Size by Type (2015-2020)
4.2 Global Cannabis-based Medicines Forecasted Market Size by Type (2021-2026)
5 CANNABIS-BASED MEDICINES BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Cannabis-based Medicines Market Size by Application (2015-2020)
5.2 Global Cannabis-based Medicines Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Cannabis-based Medicines Market Size (2015-2020)
6.2 Cannabis-based Medicines Key Players in North America (2019-2020)
6.3 North America Cannabis-based Medicines Market Size by Type (2015-2020)
6.4 North America Cannabis-based Medicines Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Cannabis-based Medicines Market Size (2015-2020)
7.2 Cannabis-based Medicines Key Players in Europe (2019-2020)
7.3 Europe Cannabis-based Medicines Market Size by Type (2015-2020)
7.4 Europe Cannabis-based Medicines Market Size by Application (2015-2020)
8 CHINA
8.1 China Cannabis-based Medicines Market Size (2015-2020)
8.2 Cannabis-based Medicines Key Players in China (2019-2020)
8.3 China Cannabis-based Medicines Market Size by Type (2015-2020)
8.4 China Cannabis-based Medicines Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Cannabis-based Medicines Market Size (2015-2020)
9.2 Cannabis-based Medicines Key Players in Japan (2019-2020)
9.3 Japan Cannabis-based Medicines Market Size by Type (2015-2020)
9.4 Japan Cannabis-based Medicines Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia Cannabis-based Medicines Market Size (2015-2020)
10.2 Cannabis-based Medicines Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Cannabis-based Medicines Market Size by Type (2015-2020)
10.4 Southeast Asia Cannabis-based Medicines Market Size by Application (2015-2020)
11 INDIA
11.1 India Cannabis-based Medicines Market Size (2015-2020)
11.2 Cannabis-based Medicines Key Players in India (2019-2020)
11.3 India Cannabis-based Medicines Market Size by Type (2015-2020)
11.4 India Cannabis-based Medicines Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America Cannabis-based Medicines Market Size (2015-2020)
12.2 Cannabis-based Medicines Key Players in Central & South America (2019-2020)
12.3 Central & South America Cannabis-based Medicines Market Size by Type (2015-2020)
12.4 Central & South America Cannabis-based Medicines Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 GW Pharmaceuticals plc
13.1.1 GW Pharmaceuticals plc Company Details
13.1.2 GW Pharmaceuticals plc Business Overview and Its Total Revenue
13.1.3 GW Pharmaceuticals plc Cannabis-based Medicines Introduction
13.1.4 GW Pharmaceuticals plc Revenue in Cannabis-based Medicines Business (2015-2020))
13.1.5 GW Pharmaceuticals plc Recent Development
13.2 INSYS Therapeutics
13.2.1 INSYS Therapeutics Company Details
13.2.2 INSYS Therapeutics Business Overview and Its Total Revenue
13.2.3 INSYS Therapeutics Cannabis-based Medicines Introduction
13.2.4 INSYS Therapeutics Revenue in Cannabis-based Medicines Business (2015-2020)
13.2.5 INSYS Therapeutics Recent Development
13.3 Aequus Pharmaceuticals
13.3.1 Aequus Pharmaceuticals Company Details
13.3.2 Aequus Pharmaceuticals Business Overview and Its Total Revenue
13.3.3 Aequus Pharmaceuticals Cannabis-based Medicines Introduction
13.3.4 Aequus Pharmaceuticals Revenue in Cannabis-based Medicines Business (2015-2020)
13.3.5 Aequus Pharmaceuticals Recent Development
13.4 Axim Biotechnologies
13.4.1 Axim Biotechnologies Company Details
13.4.2 Axim Biotechnologies Business Overview and Its Total Revenue
13.4.3 Axim Biotechnologies Cannabis-based Medicines Introduction
13.4.4 Axim Biotechnologies Revenue in Cannabis-based Medicines Business (2015-2020)
13.4.5 Axim Biotechnologies Recent Development
13.5 Revive Therapeutics
13.5.1 Revive Therapeutics Company Details
13.5.2 Revive Therapeutics Business Overview and Its Total Revenue
13.5.3 Revive Therapeutics Cannabis-based Medicines Introduction
13.5.4 Revive Therapeutics Revenue in Cannabis-based Medicines Business (2015-2020)
13.5.5 Revive Therapeutics Recent Development
13.6 MGC Pharmaceuticals
13.6.1 MGC Pharmaceuticals Company Details
13.6.2 MGC Pharmaceuticals Business Overview and Its Total Revenue
13.6.3 MGC Pharmaceuticals Cannabis-based Medicines Introduction
13.6.4 MGC Pharmaceuticals Revenue in Cannabis-based Medicines Business (2015-2020)
13.6.5 MGC Pharmaceuticals Recent Development
13.7 ECHO Pharmaceuticals
13.7.1 ECHO Pharmaceuticals Company Details
13.7.2 ECHO Pharmaceuticals Business Overview and Its Total Revenue
13.7.3 ECHO Pharmaceuticals Cannabis-based Medicines Introduction
13.7.4 ECHO Pharmaceuticals Revenue in Cannabis-based Medicines Business (2015-2020)
13.7.5 ECHO Pharmaceuticals Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Cannabis-based Medicines Revenue
1.4 Market Analysis by Type
1.4.1 Global Cannabis-based Medicines Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 CBD (Cannabidiol) Based
1.4.3 THC (Tetrahydrocannabinol) Based
1.4.4 Others
1.5 Market by Application
1.5.1 Global Cannabis-based Medicines Market Share by Application: 2020 VS 2026
1.5.2 Oral Solution
1.5.3 Tablets
1.5.4 Patches
1.5.5 Others
1.6 Coronavirus Disease 2019 (Covid-19): Cannabis-based Medicines Industry Impact
1.6.1 How the Covid-19 is Affecting the Cannabis-based Medicines Industry
1.6.1.1 Cannabis-based Medicines Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Cannabis-based Medicines Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Cannabis-based Medicines Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Cannabis-based Medicines Market Perspective (2015-2026)
2.2 Cannabis-based Medicines Growth Trends by Regions
2.2.1 Cannabis-based Medicines Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Cannabis-based Medicines Historic Market Share by Regions (2015-2020)
2.2.3 Cannabis-based Medicines Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Cannabis-based Medicines Market Growth Strategy
2.3.6 Primary Interviews with Key Cannabis-based Medicines Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Cannabis-based Medicines Players by Market Size
3.1.1 Global Top Cannabis-based Medicines Players by Revenue (2015-2020)
3.1.2 Global Cannabis-based Medicines Revenue Market Share by Players (2015-2020)
3.1.3 Global Cannabis-based Medicines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Cannabis-based Medicines Market Concentration Ratio
3.2.1 Global Cannabis-based Medicines Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Cannabis-based Medicines Revenue in 2019
3.3 Cannabis-based Medicines Key Players Head office and Area Served
3.4 Key Players Cannabis-based Medicines Product Solution and Service
3.5 Date of Enter into Cannabis-based Medicines Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Cannabis-based Medicines Historic Market Size by Type (2015-2020)
4.2 Global Cannabis-based Medicines Forecasted Market Size by Type (2021-2026)
5 CANNABIS-BASED MEDICINES BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Cannabis-based Medicines Market Size by Application (2015-2020)
5.2 Global Cannabis-based Medicines Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Cannabis-based Medicines Market Size (2015-2020)
6.2 Cannabis-based Medicines Key Players in North America (2019-2020)
6.3 North America Cannabis-based Medicines Market Size by Type (2015-2020)
6.4 North America Cannabis-based Medicines Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Cannabis-based Medicines Market Size (2015-2020)
7.2 Cannabis-based Medicines Key Players in Europe (2019-2020)
7.3 Europe Cannabis-based Medicines Market Size by Type (2015-2020)
7.4 Europe Cannabis-based Medicines Market Size by Application (2015-2020)
8 CHINA
8.1 China Cannabis-based Medicines Market Size (2015-2020)
8.2 Cannabis-based Medicines Key Players in China (2019-2020)
8.3 China Cannabis-based Medicines Market Size by Type (2015-2020)
8.4 China Cannabis-based Medicines Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Cannabis-based Medicines Market Size (2015-2020)
9.2 Cannabis-based Medicines Key Players in Japan (2019-2020)
9.3 Japan Cannabis-based Medicines Market Size by Type (2015-2020)
9.4 Japan Cannabis-based Medicines Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia Cannabis-based Medicines Market Size (2015-2020)
10.2 Cannabis-based Medicines Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Cannabis-based Medicines Market Size by Type (2015-2020)
10.4 Southeast Asia Cannabis-based Medicines Market Size by Application (2015-2020)
11 INDIA
11.1 India Cannabis-based Medicines Market Size (2015-2020)
11.2 Cannabis-based Medicines Key Players in India (2019-2020)
11.3 India Cannabis-based Medicines Market Size by Type (2015-2020)
11.4 India Cannabis-based Medicines Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America Cannabis-based Medicines Market Size (2015-2020)
12.2 Cannabis-based Medicines Key Players in Central & South America (2019-2020)
12.3 Central & South America Cannabis-based Medicines Market Size by Type (2015-2020)
12.4 Central & South America Cannabis-based Medicines Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 GW Pharmaceuticals plc
13.1.1 GW Pharmaceuticals plc Company Details
13.1.2 GW Pharmaceuticals plc Business Overview and Its Total Revenue
13.1.3 GW Pharmaceuticals plc Cannabis-based Medicines Introduction
13.1.4 GW Pharmaceuticals plc Revenue in Cannabis-based Medicines Business (2015-2020))
13.1.5 GW Pharmaceuticals plc Recent Development
13.2 INSYS Therapeutics
13.2.1 INSYS Therapeutics Company Details
13.2.2 INSYS Therapeutics Business Overview and Its Total Revenue
13.2.3 INSYS Therapeutics Cannabis-based Medicines Introduction
13.2.4 INSYS Therapeutics Revenue in Cannabis-based Medicines Business (2015-2020)
13.2.5 INSYS Therapeutics Recent Development
13.3 Aequus Pharmaceuticals
13.3.1 Aequus Pharmaceuticals Company Details
13.3.2 Aequus Pharmaceuticals Business Overview and Its Total Revenue
13.3.3 Aequus Pharmaceuticals Cannabis-based Medicines Introduction
13.3.4 Aequus Pharmaceuticals Revenue in Cannabis-based Medicines Business (2015-2020)
13.3.5 Aequus Pharmaceuticals Recent Development
13.4 Axim Biotechnologies
13.4.1 Axim Biotechnologies Company Details
13.4.2 Axim Biotechnologies Business Overview and Its Total Revenue
13.4.3 Axim Biotechnologies Cannabis-based Medicines Introduction
13.4.4 Axim Biotechnologies Revenue in Cannabis-based Medicines Business (2015-2020)
13.4.5 Axim Biotechnologies Recent Development
13.5 Revive Therapeutics
13.5.1 Revive Therapeutics Company Details
13.5.2 Revive Therapeutics Business Overview and Its Total Revenue
13.5.3 Revive Therapeutics Cannabis-based Medicines Introduction
13.5.4 Revive Therapeutics Revenue in Cannabis-based Medicines Business (2015-2020)
13.5.5 Revive Therapeutics Recent Development
13.6 MGC Pharmaceuticals
13.6.1 MGC Pharmaceuticals Company Details
13.6.2 MGC Pharmaceuticals Business Overview and Its Total Revenue
13.6.3 MGC Pharmaceuticals Cannabis-based Medicines Introduction
13.6.4 MGC Pharmaceuticals Revenue in Cannabis-based Medicines Business (2015-2020)
13.6.5 MGC Pharmaceuticals Recent Development
13.7 ECHO Pharmaceuticals
13.7.1 ECHO Pharmaceuticals Company Details
13.7.2 ECHO Pharmaceuticals Business Overview and Its Total Revenue
13.7.3 ECHO Pharmaceuticals Cannabis-based Medicines Introduction
13.7.4 ECHO Pharmaceuticals Revenue in Cannabis-based Medicines Business (2015-2020)
13.7.5 ECHO Pharmaceuticals Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
LIST OF TABLES
Table 1. Cannabis-based Medicines Key Market Segments
Table 2. Key Players Covered: Ranking by Cannabis-based Medicines Revenue
Table 3. Ranking of Global Top Cannabis-based Medicines Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Cannabis-based Medicines Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of CBD (Cannabidiol) Based
Table 6. Key Players of THC (Tetrahydrocannabinol) Based
Table 7. Key Players of Others
Table 8. COVID-19 Impact Global Market: (Four Cannabis-based Medicines Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Cannabis-based Medicines Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Cannabis-based Medicines Players to Combat Covid-19 Impact
Table 13. Global Cannabis-based Medicines Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Cannabis-based Medicines Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Cannabis-based Medicines Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Cannabis-based Medicines Market Share by Regions (2015-2020)
Table 17. Global Cannabis-based Medicines Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Cannabis-based Medicines Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Cannabis-based Medicines Market Growth Strategy
Table 23. Main Points Interviewed from Key Cannabis-based Medicines Players
Table 24. Global Cannabis-based Medicines Revenue by Players (2015-2020) (Million US$)
Table 25. Global Cannabis-based Medicines Market Share by Players (2015-2020)
Table 26. Global Top Cannabis-based Medicines Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cannabis-based Medicines as of 2019)
Table 27. Global Cannabis-based Medicines by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Cannabis-based Medicines Product Solution and Service
Table 30. Date of Enter into Cannabis-based Medicines Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Cannabis-based Medicines Market Size by Type (2015-2020) (Million US$)
Table 33. Global Cannabis-based Medicines Market Size Share by Type (2015-2020)
Table 34. Global Cannabis-based Medicines Revenue Market Share by Type (2021-2026)
Table 35. Global Cannabis-based Medicines Market Size Share by Application (2015-2020)
Table 36. Global Cannabis-based Medicines Market Size by Application (2015-2020) (Million US$)
Table 37. Global Cannabis-based Medicines Market Size Share by Application (2021-2026)
Table 38. North America Key Players Cannabis-based Medicines Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Cannabis-based Medicines Market Share (2019-2020)
Table 40. North America Cannabis-based Medicines Market Size by Type (2015-2020) (Million US$)
Table 41. North America Cannabis-based Medicines Market Share by Type (2015-2020)
Table 42. North America Cannabis-based Medicines Market Size by Application (2015-2020) (Million US$)
Table 43. North America Cannabis-based Medicines Market Share by Application (2015-2020)
Table 44. Europe Key Players Cannabis-based Medicines Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Cannabis-based Medicines Market Share (2019-2020)
Table 46. Europe Cannabis-based Medicines Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Cannabis-based Medicines Market Share by Type (2015-2020)
Table 48. Europe Cannabis-based Medicines Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Cannabis-based Medicines Market Share by Application (2015-2020)
Table 50. China Key Players Cannabis-based Medicines Revenue (2019-2020) (Million US$)
Table 51. China Key Players Cannabis-based Medicines Market Share (2019-2020)
Table 52. China Cannabis-based Medicines Market Size by Type (2015-2020) (Million US$)
Table 53. China Cannabis-based Medicines Market Share by Type (2015-2020)
Table 54. China Cannabis-based Medicines Market Size by Application (2015-2020) (Million US$)
Table 55. China Cannabis-based Medicines Market Share by Application (2015-2020)
Table 56. Japan Key Players Cannabis-based Medicines Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players Cannabis-based Medicines Market Share (2019-2020)
Table 58. Japan Cannabis-based Medicines Market Size by Type (2015-2020) (Million US$)
Table 59. Japan Cannabis-based Medicines Market Share by Type (2015-2020)
Table 60. Japan Cannabis-based Medicines Market Size by Application (2015-2020) (Million US$)
Table 61. Japan Cannabis-based Medicines Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players Cannabis-based Medicines Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players Cannabis-based Medicines Market Share (2019-2020)
Table 64. Southeast Asia Cannabis-based Medicines Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia Cannabis-based Medicines Market Share by Type (2015-2020)
Table 66. Southeast Asia Cannabis-based Medicines Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia Cannabis-based Medicines Market Share by Application (2015-2020)
Table 68. India Key Players Cannabis-based Medicines Revenue (2019-2020) (Million US$)
Table 69. India Key Players Cannabis-based Medicines Market Share (2019-2020)
Table 70. India Cannabis-based Medicines Market Size by Type (2015-2020) (Million US$)
Table 71. India Cannabis-based Medicines Market Share by Type (2015-2020)
Table 72. India Cannabis-based Medicines Market Size by Application (2015-2020) (Million US$)
Table 73. India Cannabis-based Medicines Market Share by Application (2015-2020)
Table 74. Central & South America Key Players Cannabis-based Medicines Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players Cannabis-based Medicines Market Share (2019-2020)
Table 76. Central & South America Cannabis-based Medicines Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America Cannabis-based Medicines Market Share by Type (2015-2020)
Table 78. Central & South America Cannabis-based Medicines Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America Cannabis-based Medicines Market Share by Application (2015-2020)
Table 80. GW Pharmaceuticals plc Company Details
Table 81. GW Pharmaceuticals plc Business Overview
Table 82. GW Pharmaceuticals plc Product
Table 83. GW Pharmaceuticals plc Revenue in Cannabis-based Medicines Business (2015-2020) (Million US$)
Table 84. GW Pharmaceuticals plc Recent Development
Table 85. INSYS Therapeutics Company Details
Table 86. INSYS Therapeutics Business Overview
Table 87. INSYS Therapeutics Product
Table 88. INSYS Therapeutics Revenue in Cannabis-based Medicines Business (2015-2020) (Million US$)
Table 89. INSYS Therapeutics Recent Development
Table 90. Aequus Pharmaceuticals Company Details
Table 91. Aequus Pharmaceuticals Business Overview
Table 92. Aequus Pharmaceuticals Product
Table 93. Aequus Pharmaceuticals Revenue in Cannabis-based Medicines Business (2015-2020) (Million US$)
Table 94. Aequus Pharmaceuticals Recent Development
Table 95. Axim Biotechnologies Company Details
Table 96. Axim Biotechnologies Business Overview
Table 97. Axim Biotechnologies Product
Table 98. Axim Biotechnologies Revenue in Cannabis-based Medicines Business (2015-2020) (Million US$)
Table 99. Axim Biotechnologies Recent Development
Table 100. Revive Therapeutics Company Details
Table 101. Revive Therapeutics Business Overview
Table 102. Revive Therapeutics Product
Table 103. Revive Therapeutics Revenue in Cannabis-based Medicines Business (2015-2020) (Million US$)
Table 104. Revive Therapeutics Recent Development
Table 105. MGC Pharmaceuticals Company Details
Table 106. MGC Pharmaceuticals Business Overview
Table 107. MGC Pharmaceuticals Product
Table 108. MGC Pharmaceuticals Revenue in Cannabis-based Medicines Business (2015-2020) (Million US$)
Table 109. MGC Pharmaceuticals Recent Development
Table 110. ECHO Pharmaceuticals Company Details
Table 111. ECHO Pharmaceuticals Business Overview
Table 112. ECHO Pharmaceuticals Product
Table 113. ECHO Pharmaceuticals Revenue in Cannabis-based Medicines Business (2015-2020) (Million US$)
Table 114. ECHO Pharmaceuticals Recent Development
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
Table 1. Cannabis-based Medicines Key Market Segments
Table 2. Key Players Covered: Ranking by Cannabis-based Medicines Revenue
Table 3. Ranking of Global Top Cannabis-based Medicines Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Cannabis-based Medicines Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of CBD (Cannabidiol) Based
Table 6. Key Players of THC (Tetrahydrocannabinol) Based
Table 7. Key Players of Others
Table 8. COVID-19 Impact Global Market: (Four Cannabis-based Medicines Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Cannabis-based Medicines Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Cannabis-based Medicines Players to Combat Covid-19 Impact
Table 13. Global Cannabis-based Medicines Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Cannabis-based Medicines Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Cannabis-based Medicines Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Cannabis-based Medicines Market Share by Regions (2015-2020)
Table 17. Global Cannabis-based Medicines Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Cannabis-based Medicines Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Cannabis-based Medicines Market Growth Strategy
Table 23. Main Points Interviewed from Key Cannabis-based Medicines Players
Table 24. Global Cannabis-based Medicines Revenue by Players (2015-2020) (Million US$)
Table 25. Global Cannabis-based Medicines Market Share by Players (2015-2020)
Table 26. Global Top Cannabis-based Medicines Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cannabis-based Medicines as of 2019)
Table 27. Global Cannabis-based Medicines by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Cannabis-based Medicines Product Solution and Service
Table 30. Date of Enter into Cannabis-based Medicines Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Cannabis-based Medicines Market Size by Type (2015-2020) (Million US$)
Table 33. Global Cannabis-based Medicines Market Size Share by Type (2015-2020)
Table 34. Global Cannabis-based Medicines Revenue Market Share by Type (2021-2026)
Table 35. Global Cannabis-based Medicines Market Size Share by Application (2015-2020)
Table 36. Global Cannabis-based Medicines Market Size by Application (2015-2020) (Million US$)
Table 37. Global Cannabis-based Medicines Market Size Share by Application (2021-2026)
Table 38. North America Key Players Cannabis-based Medicines Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Cannabis-based Medicines Market Share (2019-2020)
Table 40. North America Cannabis-based Medicines Market Size by Type (2015-2020) (Million US$)
Table 41. North America Cannabis-based Medicines Market Share by Type (2015-2020)
Table 42. North America Cannabis-based Medicines Market Size by Application (2015-2020) (Million US$)
Table 43. North America Cannabis-based Medicines Market Share by Application (2015-2020)
Table 44. Europe Key Players Cannabis-based Medicines Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Cannabis-based Medicines Market Share (2019-2020)
Table 46. Europe Cannabis-based Medicines Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Cannabis-based Medicines Market Share by Type (2015-2020)
Table 48. Europe Cannabis-based Medicines Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Cannabis-based Medicines Market Share by Application (2015-2020)
Table 50. China Key Players Cannabis-based Medicines Revenue (2019-2020) (Million US$)
Table 51. China Key Players Cannabis-based Medicines Market Share (2019-2020)
Table 52. China Cannabis-based Medicines Market Size by Type (2015-2020) (Million US$)
Table 53. China Cannabis-based Medicines Market Share by Type (2015-2020)
Table 54. China Cannabis-based Medicines Market Size by Application (2015-2020) (Million US$)
Table 55. China Cannabis-based Medicines Market Share by Application (2015-2020)
Table 56. Japan Key Players Cannabis-based Medicines Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players Cannabis-based Medicines Market Share (2019-2020)
Table 58. Japan Cannabis-based Medicines Market Size by Type (2015-2020) (Million US$)
Table 59. Japan Cannabis-based Medicines Market Share by Type (2015-2020)
Table 60. Japan Cannabis-based Medicines Market Size by Application (2015-2020) (Million US$)
Table 61. Japan Cannabis-based Medicines Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players Cannabis-based Medicines Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players Cannabis-based Medicines Market Share (2019-2020)
Table 64. Southeast Asia Cannabis-based Medicines Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia Cannabis-based Medicines Market Share by Type (2015-2020)
Table 66. Southeast Asia Cannabis-based Medicines Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia Cannabis-based Medicines Market Share by Application (2015-2020)
Table 68. India Key Players Cannabis-based Medicines Revenue (2019-2020) (Million US$)
Table 69. India Key Players Cannabis-based Medicines Market Share (2019-2020)
Table 70. India Cannabis-based Medicines Market Size by Type (2015-2020) (Million US$)
Table 71. India Cannabis-based Medicines Market Share by Type (2015-2020)
Table 72. India Cannabis-based Medicines Market Size by Application (2015-2020) (Million US$)
Table 73. India Cannabis-based Medicines Market Share by Application (2015-2020)
Table 74. Central & South America Key Players Cannabis-based Medicines Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players Cannabis-based Medicines Market Share (2019-2020)
Table 76. Central & South America Cannabis-based Medicines Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America Cannabis-based Medicines Market Share by Type (2015-2020)
Table 78. Central & South America Cannabis-based Medicines Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America Cannabis-based Medicines Market Share by Application (2015-2020)
Table 80. GW Pharmaceuticals plc Company Details
Table 81. GW Pharmaceuticals plc Business Overview
Table 82. GW Pharmaceuticals plc Product
Table 83. GW Pharmaceuticals plc Revenue in Cannabis-based Medicines Business (2015-2020) (Million US$)
Table 84. GW Pharmaceuticals plc Recent Development
Table 85. INSYS Therapeutics Company Details
Table 86. INSYS Therapeutics Business Overview
Table 87. INSYS Therapeutics Product
Table 88. INSYS Therapeutics Revenue in Cannabis-based Medicines Business (2015-2020) (Million US$)
Table 89. INSYS Therapeutics Recent Development
Table 90. Aequus Pharmaceuticals Company Details
Table 91. Aequus Pharmaceuticals Business Overview
Table 92. Aequus Pharmaceuticals Product
Table 93. Aequus Pharmaceuticals Revenue in Cannabis-based Medicines Business (2015-2020) (Million US$)
Table 94. Aequus Pharmaceuticals Recent Development
Table 95. Axim Biotechnologies Company Details
Table 96. Axim Biotechnologies Business Overview
Table 97. Axim Biotechnologies Product
Table 98. Axim Biotechnologies Revenue in Cannabis-based Medicines Business (2015-2020) (Million US$)
Table 99. Axim Biotechnologies Recent Development
Table 100. Revive Therapeutics Company Details
Table 101. Revive Therapeutics Business Overview
Table 102. Revive Therapeutics Product
Table 103. Revive Therapeutics Revenue in Cannabis-based Medicines Business (2015-2020) (Million US$)
Table 104. Revive Therapeutics Recent Development
Table 105. MGC Pharmaceuticals Company Details
Table 106. MGC Pharmaceuticals Business Overview
Table 107. MGC Pharmaceuticals Product
Table 108. MGC Pharmaceuticals Revenue in Cannabis-based Medicines Business (2015-2020) (Million US$)
Table 109. MGC Pharmaceuticals Recent Development
Table 110. ECHO Pharmaceuticals Company Details
Table 111. ECHO Pharmaceuticals Business Overview
Table 112. ECHO Pharmaceuticals Product
Table 113. ECHO Pharmaceuticals Revenue in Cannabis-based Medicines Business (2015-2020) (Million US$)
Table 114. ECHO Pharmaceuticals Recent Development
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Cannabis-based Medicines Market Share by Type: 2020 VS 2026
Figure 2. CBD (Cannabidiol) Based Features
Figure 3. THC (Tetrahydrocannabinol) Based Features
Figure 4. Others Features
Figure 5. Global Cannabis-based Medicines Market Share by Application: 2020 VS 2026
Figure 6. Oral Solution Case Studies
Figure 7. Tablets Case Studies
Figure 8. Patches Case Studies
Figure 9. Others Case Studies
Figure 10. Cannabis-based Medicines Report Years Considered
Figure 11. Global Cannabis-based Medicines Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Cannabis-based Medicines Market Share by Regions: 2020 VS 2026
Figure 13. Global Cannabis-based Medicines Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Cannabis-based Medicines Market Share by Players in 2019
Figure 16. Global Top Cannabis-based Medicines Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cannabis-based Medicines as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Cannabis-based Medicines Revenue in 2019
Figure 18. North America Cannabis-based Medicines Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Cannabis-based Medicines Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Cannabis-based Medicines Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Cannabis-based Medicines Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Cannabis-based Medicines Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Cannabis-based Medicines Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Cannabis-based Medicines Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. GW Pharmaceuticals plc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. GW Pharmaceuticals plc Revenue Growth Rate in Cannabis-based Medicines Business (2015-2020)
Figure 27. INSYS Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. INSYS Therapeutics Revenue Growth Rate in Cannabis-based Medicines Business (2015-2020)
Figure 29. Aequus Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Aequus Pharmaceuticals Revenue Growth Rate in Cannabis-based Medicines Business (2015-2020)
Figure 31. Axim Biotechnologies Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Axim Biotechnologies Revenue Growth Rate in Cannabis-based Medicines Business (2015-2020)
Figure 33. Revive Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Revive Therapeutics Revenue Growth Rate in Cannabis-based Medicines Business (2015-2020)
Figure 35. MGC Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. MGC Pharmaceuticals Revenue Growth Rate in Cannabis-based Medicines Business (2015-2020)
Figure 37. ECHO Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. ECHO Pharmaceuticals Revenue Growth Rate in Cannabis-based Medicines Business (2015-2020)
Figure 39. Bottom-up and Top-down Approaches for This Report
Figure 40. Data Triangulation
Figure 41. Key Executives Interviewed
Figure 1. Global Cannabis-based Medicines Market Share by Type: 2020 VS 2026
Figure 2. CBD (Cannabidiol) Based Features
Figure 3. THC (Tetrahydrocannabinol) Based Features
Figure 4. Others Features
Figure 5. Global Cannabis-based Medicines Market Share by Application: 2020 VS 2026
Figure 6. Oral Solution Case Studies
Figure 7. Tablets Case Studies
Figure 8. Patches Case Studies
Figure 9. Others Case Studies
Figure 10. Cannabis-based Medicines Report Years Considered
Figure 11. Global Cannabis-based Medicines Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Cannabis-based Medicines Market Share by Regions: 2020 VS 2026
Figure 13. Global Cannabis-based Medicines Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Cannabis-based Medicines Market Share by Players in 2019
Figure 16. Global Top Cannabis-based Medicines Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cannabis-based Medicines as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Cannabis-based Medicines Revenue in 2019
Figure 18. North America Cannabis-based Medicines Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Cannabis-based Medicines Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Cannabis-based Medicines Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Cannabis-based Medicines Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Cannabis-based Medicines Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Cannabis-based Medicines Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Cannabis-based Medicines Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. GW Pharmaceuticals plc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. GW Pharmaceuticals plc Revenue Growth Rate in Cannabis-based Medicines Business (2015-2020)
Figure 27. INSYS Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. INSYS Therapeutics Revenue Growth Rate in Cannabis-based Medicines Business (2015-2020)
Figure 29. Aequus Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Aequus Pharmaceuticals Revenue Growth Rate in Cannabis-based Medicines Business (2015-2020)
Figure 31. Axim Biotechnologies Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Axim Biotechnologies Revenue Growth Rate in Cannabis-based Medicines Business (2015-2020)
Figure 33. Revive Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Revive Therapeutics Revenue Growth Rate in Cannabis-based Medicines Business (2015-2020)
Figure 35. MGC Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. MGC Pharmaceuticals Revenue Growth Rate in Cannabis-based Medicines Business (2015-2020)
Figure 37. ECHO Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. ECHO Pharmaceuticals Revenue Growth Rate in Cannabis-based Medicines Business (2015-2020)
Figure 39. Bottom-up and Top-down Approaches for This Report
Figure 40. Data Triangulation
Figure 41. Key Executives Interviewed
